Nisa Investment Advisors’s iTeos Therapeutics ITOS Stock Holding History

Nisa Investment Advisors’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,939	Closed	-$19.3K	–	3037
2025 Q2	$19.3K	Buy	1,939 +1,756	+960%	+$14.1K	﹤0.01%	1955
2025 Q1	$1.09K	Sell	183 -230	-56%	-$1.69K	﹤0.01%	2618
2024 Q4	$3.17K	Buy	413 +280	+211%	+$2.41K	﹤0.01%	2375
2024 Q3	$1.36K	Buy	133 +40	+43%	+$610	﹤0.01%	2501
2024 Q2	$1.38K	Buy	+93	New	+$1.33K	﹤0.01%	2445
2023 Q4	–	Sell	-11	Closed	-$120	–	2687
2023 Q3	$120	Sell	11 -110	-91%	-$1.41K	﹤0.01%	2722
2023 Q2	$1.6K	Sell	121 -1,170	-91%	-$16.7K	﹤0.01%	2380
2023 Q1	$18K	Buy	1,291 +1,260	+4,065%	+$22.6K	﹤0.01%	2037
2022 Q4	$1K	Buy	+31	New	+$606	﹤0.01%	2450
2022 Q2	–	Sell	-2,600	Closed	-$84K	–	2437
2022 Q1	$84K	Hold	2,600	–	–	﹤0.01%	1684
2021 Q4	$95K	Buy	+2,600	New	+$86.5K	﹤0.01%	1536

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nisa Investment Advisors's ITOS Position: Q3 2025 in Review

Nisa Investment Advisors sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 1,939 shares — an estimated $19.3K sold.

Nisa Investment Advisors first reported a position in ITOS in Q4 2021 and held it in 11 quarters. The position peaked at $95K in Q4 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Nisa Investment Advisors reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Nisa Investment Advisors sold 1,939 iTeos Therapeutics shares in Q3 2025, an estimated $19.3K.
Nisa Investment Advisors first reported a position in iTeos Therapeutics in Q4 2021 and held it in 11 quarters.
Nisa Investment Advisors's iTeos Therapeutics position peaked at $95K in Q4 2021.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.